Gp120 on HIV-1 Virions Lacks O-Linked Carbohydrate
- PMID: 25915761
- PMCID: PMC4410959
- DOI: 10.1371/journal.pone.0124784
Gp120 on HIV-1 Virions Lacks O-Linked Carbohydrate
Abstract
As HIV-1-encoded envelope protein traverses the secretory pathway, it may be modified with N- and O-linked carbohydrate. When the gp120s of HIV-1 NL4-3, HIV-1 YU2, HIV-1 Bal, HIV-1 JRFL, and HIV-1 JRCSF were expressed as secreted proteins, the threonine at consensus position 499 was found to be O-glycosylated. For SIVmac239, the corresponding threonine was also glycosylated when gp120 was recombinantly expressed. Similarly-positioned, highly-conserved threonines in the influenza A virus H1N1 HA1 and H5N1 HA1 envelope proteins were also found to carry O-glycans when expressed as secreted proteins. In all cases, the threonines were modified predominantly with disialylated core 1 glycans, together with related core 1 and core 2 structures. Secreted HIV-1 gp140 was modified to a lesser extent with mainly monosialylated core 1 O-glycans, suggesting that the ectodomain of the gp41 transmembrane component may limit the accessibility of Thr499 to glycosyltransferases. In striking contrast to these findings, gp120 on purified virions of HIV-1 Bal and SIV CP-MAC lacked any detectable O-glycosylation of the C-terminal threonine. Our results indicate the absence of O-linked carbohydrates on Thr499 as it exists on the surface of virions and suggest caution in the interpretation of analyses of post-translational modifications that utilize recombinant forms of envelope protein.
Conflict of interest statement
Figures





References
-
- Damonte EB, Mersich SE, Candurra NA. Intracellular processing and transport of Junin virus glycoproteins influences virion infectivity. Virus Res. 1994;34: 317–326. - PubMed
-
- Lazarowitz SG, Compans RW, Choppin PW. Proteolytic cleavage of the hemagglutinin polypeptide of influenza virus. Function of the uncleaved polypeptide HA. Virology. 1973;52: 199–212. - PubMed
-
- McCune JM, Rabin LB, Feinberg MB, Lieberman M, Kosek JC, Reyes GR, et al. Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus. Cell. 1988;53: 55–67. - PubMed
-
- Hallenberger S, Bosch V, Angliker H, Shaw E, Klenk HD, Garten W. Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160. Nature. 1992;360: 358–361. - PubMed
-
- Kuiken C, Foley B, Leitner T, Apetrei C, Hahn B, Mizrachi I, et al. HIV sequence compendium.: Theoretical Biology and Biophysics Group. 2010.
Publication types
MeSH terms
Substances
Grants and funding
- R01 AI104523/AI/NIAID NIH HHS/United States
- R01-AI025328/AI/NIAID NIH HHS/United States
- BB/F008309/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- R01-AI104523/AI/NIAID NIH HHS/United States
- 082098/WT_/Wellcome Trust/United Kingdom
- P51-RR000168/RR/NCRR NIH HHS/United States
- BBF0083091/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- HHSN261200800001C/RC/CCR NIH HHS/United States
- P30 AI060354/AI/NIAID NIH HHS/United States
- HHSN261200800001E/CA/NCI NIH HHS/United States
- P51 RR000168/RR/NCRR NIH HHS/United States
- P30-AI060354/AI/NIAID NIH HHS/United States
- BB/K015164/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- R01 AI025328/AI/NIAID NIH HHS/United States
- BBK016164/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- WT_/Wellcome Trust/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous